Previous studies have demonstrated that increased CD4+CD25+FoxP3+ Treg cells in RCC were related to worse outcomes [33], and the FoxP3+ tumor cells have been detected in the tumor–normal tissue borders [37]. The gene discussed is CD4; the disease is renal cell adenocarcinoma.